Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update
International Journal of Urology · 2023-10 · 30 (10) · 808-817
DOI: 10.1111/iju.15213 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Urology, online erschienen am 06.06.2023. Verfasst von Takahiro Osawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hokkaido University Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Angiomyolipoma, Kidney Neoplasms, Tuberous Sclerosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
New clinical issues have been raised through an interval of 7 years from the previous version (2016). In this study, we update the “Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma” as a 2023 version under guidance by the Japanese Urological Association. The present guidelines were cooperatively prepared by the Japanese Urological Association and Japanese Society of Tuberous Sclerosis Complex; committee members belonging to one of the two societies or specializing in the treatment of this disease were selected to prepare the guidelines in accordance with the “Guidance for preparing treatment guidelines” published by Minds (2020 version). The “Introduction” consisted of four sections, “Background Questions (BQ)” consisted of four sections, “Clinical Questions (CQ)” consisted of three sections, and “Future Questions (FQ)” consisted of three sections (total: 14 sections). Concerning CQ, an agreement was confirmed through voting by the committee members based on the direction and strength of recommendation, accuracy of evidence, and recommendation comments. The present guidelines were updated based on the current evidence. We hope that the guidelines will provide guiding principles for the treatment of tuberous sclerosis complex‐associated renal angiomyolipoma to many urologists, becoming a foundation for subsequent updating.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Hokkaido University Hospital, Sapporo, Japan.
- Department of Urology, Keio University School of Medicine, Tokyo, Japan.
- Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
- Department of Radiology, School of Medicine and Graduate School of Medicine, Juntendo University, Tokyo, Japan.
- Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Department of Urology and Department of Molecular Oncology, Niigata University Graduate School of Medicine, Niigata, Japan.
ORCID-Profile: Takahiro Osawa, Yoshihiko Tomita, Yasuhisa Fujii
Zitieren
APA
Osawa, T., Oya, M., Okanishi, T., Kuwatsuru, R., Kawano, H., Tomita, Y., Niida, Y., Nonomura, N., Hatano, T., Fujii, Y., Mizuguchi, M., & Shinohara, N. (2023). Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update. International Journal of Urology, 30(10), 808-817. https://doi.org/10.1111/iju.15213
Vancouver
Osawa T, Oya M, Okanishi T, Kuwatsuru R, Kawano H, Tomita Y, et al. Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update. International Journal of Urology. 2023;30(10):808-817. doi:10.1111/iju.15213
BibTeX
@article{Osawa2023,
author = {Osawa, Takahiro and Oya, Mototsugu and Okanishi, Tohru and Kuwatsuru, Ryohei and Kawano, Haruna and Tomita, Yoshihiko and Niida, Yo and Nonomura, Norio and Hatano, Takashi and Fujii, Yasuhisa and Mizuguchi, Masashi and Shinohara, Nobuo},
title = {Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update},
journal = {International Journal of Urology},
year = {2023},
volume = {30},
number = {10},
pages = {808--817},
doi = {10.1111/iju.15213}
}
EUVIMED